ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
July 2025
Latest News
DOE issues new NEPA rule and procedures—and accelerates DOME reactor testing
Meeting a deadline set in President Trump’s May 23 executive order “Reforming Nuclear Reactor Testing at the Department of Energy,” the DOE on June 30 updated information on its National Environmental Policy Act (NEPA) rulemaking and implementation procedures and published on its website an interim final rule that rescinds existing regulations alongside new implementing procedures.
K. Kawahata, B. J. Peterson, T. Akiyama, N. Ashikawa, M. Emoto, H. Funaba, Y. Hamada, K. Ida, S. Inagaki, T. Ido, M. Isobe, M. Goto, A. Mase, S. Masuzaki, C. Michael, T. Morisaki, S. Morita, S. Muto, Y. Nagayama, Y. Nakamura, H. Nakanishi, R. Sakamoto, K. Narihara, M. Nishiura, S. Ohdachi, S. Okajima, M. Osakabe, S. Sakakibara, A. Sanin, M. Sasao, K. Sato, A. Shimizu, M. Shoji, S. Sudo, N. Tamura, K. Tanaka, K. Toi, T. Tokuzawa, E. V. Veshchev, L. N. Vyacheslavov, I. Yamada, M. Yoshinuma, LHD Experiment Group
Fusion Science and Technology | Volume 58 | Number 1 | July-August 2010 | Pages 331-344
Chapter 8. Diagnostics | Special Issue on Large Helical Device (LHD) | doi.org/10.13182/FST10-A10819
Articles are hosted by Taylor and Francis Online.
The Large Helical Device (LHD) is the world's largest heliotron-type device with l = 2, m = 10 continuous superconducting helical coils and three pairs of superconducting poloidal coils. The major and minor radii of the plasma are 3.6 to 3.9 and 0.6 to 0.65 m, respectively. A plasma with an elliptic cross section confined in the helical magnetic field rotates poloidally along the magnetic axis and has no axial symmetry. For the installation of various kinds of diagnostic instruments, large-sized ports are equipped. The diameter of the largest horizontal ports is 2410 mm, which enables us to easily access the full plasma cross section with multichannel viewing chords aligned parallel to one another. For the precise measurement of plasma quantities in a three-dimensional helical plasma, an extensive set of diagnostics has been developed with national and international collaborators and is routinely operated in LHD. The diagnostic system now consists of [approximately]50 measuring instruments and includes many challenging diagnostics that have been developed and operated for the study of LHD plasma confinement. These are classified as profile diagnostics, fluctuation diagnostics, and advanced diagnostics, some of which are selected for introduction in this article. In addition, diagnostics for the divertor and for energetic particles are discussed, along with topics that are somewhat unique to helical devices such as diagnosing three-dimensional phenomena and flux surface mapping. This large number of diagnostics in LHD rely on a data acquisition system that has broken world records for the amount of information accumulated in one shot. Finally, looking to the near future, countermeasures have been taken to protect diagnostics from the neutrons and gamma fluxes anticipated during deuterium-deuterium experiments, such as placing much of the diagnostic instrumentation behind a 2-m-thick concrete biological shield encompassing the LHD test cell.